Abeona Therapeutics, Inc. (NASDAQ: ABEO) develops and delivers gene therapy and plasma-based products for severe and life-threatening rare diseases, according to the company’s website (see here: www.AbeonaTherapeutics.com). In this SNNLive On-Location, our host spoke with Tim Miller, Ph.D., President and CEO of Abeona Therapeutics, Inc., in New York City, NY.
In this video interview, Dr. Miller and our host discuss the following topics:
- Overview of Abeona Therapeutics, Inc.
- Discusses orphan designation for company’s products
- Patient population for children diagnosed with an orphan disease
- Describes the company’s rare disease indications
- Dr. Miller’s background
- Clinical development
- Research and development
- Abeona’s team
Since speaking with Dr. Miller, the company has made the following announcements:
For more information about Abeona Therapeutics, Inc., go to: www.AbeonaTherapeutics.com
© 2017 Stock News Now
Supported by Superior Web Solutions